STOCK TITAN

Cvs Health Corp Stock Price, News & Analysis

CVS NYSE

Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.

News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.

Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.

Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.

Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.

Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.

Rhea-AI Summary

CVS Health (NYSE: CVS) updated 2025 guidance, provided 2026 guidance, and outlined a multi-year growth plan at its 2025 Investor Day on Dec 9, 2025. The company raised 2025 revenue guidance to at least $400.0B, raised adjusted operating income guidance to $14.22B–$14.39B, and confirmed 2025 cash flow from operations of $7.5B–$8.0B. CVS initiated 2026 guidance with revenue of at least $400.0B, adjusted operating income of $15.07B–$15.41B, adjusted EPS of $7.00–$7.20, and at least $10.0B cash flow from operations.

The company expects a mid‑teens adjusted EPS CAGR through 2028, announced an AI‑native open consumer engagement platform, and reiterated strategic focus across Aetna, CVS Caremark, CVS Pharmacy, and Health Care Delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.23%
Tags
none
-
Rhea-AI Summary

CVS (NYSE: CVS) released its inaugural National Economic Impact Report on Dec 5, 2025, saying its operations deliver an annual $474 billion economic impact across the U.S. and support 1.3 million jobs nationwide.

The report cites 300,000+ employees, approximately 9,000 retail pharmacy locations and >1,000 walk-in and primary care clinics, serving 185 million individuals and placing nearly 85% of Americans within 10 miles of a CVS pharmacy.

Other metrics include $58.6 billion in local, state and federal taxes, $239 million in community investments, and 84,000 volunteer hours. The report uses IMPLAN-based analysis by Parker Strategy Group.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.46%
Tags
none
-
Rhea-AI Summary

Aetna (NYSE: CVS) announced December 4, 2025 updates that simplify prior authorization, expand clinical collaboration, and add AI capabilities to the Aetna Health app.

Key actions: effective November 2025 Aetna now bundles medical and pharmacy prior authorizations for certain conditions (examples: IVF, musculoskeletal bundles including X-rays, THA/TKA, specified meds and DME). The Aetna Clinical Collaboration (ACC) program is live in 17 hospitals and is projected to reduce 30-day readmissions and length of stay by 5% when fully implemented. As part of CVS Health's $20 billion multi-year digital investment, generative AI features have launched to an initial population and will expand in early 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.33%
Tags
none
Rhea-AI Summary

Cornerstone Community Development, together with Winterwood and CVS Health (NYSE: CVS), will host the Prichard Centennial Residential Reveal & Next-Phase Preview on December 4, 2025 at 1:30 p.m. in Huntington, WV.

The event showcases newly completed residential spaces inside the historic Prichard building and previews the next restoration phase. CVS Health has invested more than $17 million in the Prichard adaptive-reuse and has invested over $21 million in affordable housing across West Virginia, helping create or preserve 800+ affordable units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.57%
Tags
none
-
Rhea-AI Summary

CVS Health (NYSE: CVS) announced that its Board elected President and CEO David Joyner as Chair of the Board, effective January 1, 2026. Michael Mahoney will remain the Board's Lead Independent Director, and Roger Farah will continue to serve on the Board after stepping down from Executive Chair.

Joyner was named President and CEO in October 2024 and the Board cited his nearly 40 years of industry experience and a year of operational, financial and cultural improvements. The company noted its workforce of more than 300,000 colleagues and said the combined Chair and CEO structure aims to support execution of long-term strategy and stockholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
management
-
Rhea-AI Summary

CVS (NYSE:CVS) announced on November 20, 2025 the launch of Joyward, a new owned brand of seasonal decor, gifts and home accents available in stores and online for the 2025 holiday season.

The initial Joyward Holiday 2025 Collection includes throws, pillows, nutcrackers, ceramic trees, curated gift sets and accessories. Joyward will expand in 2026 with new seasonal collections and trending designs. Joyward integrates with CVS fulfillment options and loyalty programs, including same-day delivery and ExtraCare/ExtraCare+ offers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
none
Rhea-AI Summary

Aetna (NYSE: CVS) launched a generative AI-powered conversational assistant embedded across its website and mobile app to simplify member navigation of benefits and care. The assistant provides plain-language answers, session-aware guidance, and dynamically generated rich UI components (maps, charts, financial breakdowns) for personalized, visual responses.

The capability entered a beta in October 2025 and access will expand through late 2025 and the first half of 2026, with full voice enablement and multimodal support (voice, text, screen reader) planned in H1 2026. The assistant will integrate with Aetna's patent-pending Care Paths to offer proactive, contextual recommendations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
AI
-
Rhea-AI Summary

Aetna (CVS Health, NYSE: CVS) said its Aetna Clinical Collaboration (ACC) program is on track to be implemented in ten hospitals by year-end 2025, with rollouts underway at AdventHealth Shawnee Mission, Houston Methodist and WakeMed.

Early indicators show ~25% of enrolled members actively engaged with an Aetna care manager and the program is projected to reduce year-over-year 30-day readmissions and hospital length of stay by 5% when fully scaled. Aetna noted it serves > 4 million Medicare members aged 65+ and plans further ACC expansion in 2026, plus ACC for Commercial lines.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
none
-
Rhea-AI Summary

CVS Health (NYSE: CVS) will hold its Investor Day on December 9, 2025. Management will discuss the company’s strategy and provide financial guidance for 2025 and 2026. The event begins at 8:00 AM ET. A live webcast link and presentation materials will be available on the Investor Relations site at investors.cvshealth.com, and the materials will be archived there for one year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.84%
Tags
none
Rhea-AI Summary

CVS Health (NYSE: CVS) reports that CVS Pharmacy customers donated more than $3 million in 2025 to local food banks and that the company is boosting its overall contribution to support Feeding America.

CVS Health committed over $2 million in 2025 to address food insecurity, has awarded more than $4 million in local grants since 2024, and notes in-store fundraising has raised over $60 million since 2020. Recent grants include $500,000 to Feeding America, $235,000 (two years) to Community Servings, and two $100,000 grants to Meals on Wheels Mercer County and Keep Growing Detroit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.9%
Tags
none

FAQ

What is the current stock price of Cvs Health (CVS)?

The current stock price of Cvs Health (CVS) is $73.49 as of April 2, 2026.

What is the market cap of Cvs Health (CVS)?

The market cap of Cvs Health (CVS) is approximately 92.2B.

CVS Rankings

CVS Stock Data

92.22B
1.26B
Healthcare Plans
Retail-drug Stores and Proprietary Stores
Link
United States
WOONSOCKET

CVS RSS Feed